WUH-LIANG HWUYIN-HSIU CHIENNI-CHUNG LEE2020-12-092020-12-0920080149-2918https://www.scopus.com/inward/record.uri?eid=2-s2.0-56049117164&doi=10.1016%2fS0149-2918%2808%2900358-5&partnerID=40&md5=44816b661003b13500569adf13814247https://scholars.lib.ntu.edu.tw/handle/123456789/525183[SDGs]SDG3article; Fabry disease; glycogen storage disease type 2; human; mutational analysis; newborn screening; prevalence; tandem mass spectrometry; treatment planningjournal article10.1016/S0149-2918(08)00358-52-s2.0-56049117164